AEON Biopharma, Inc. — Form D

AEON Biopharma, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-20. The offering totals $150.0M, of which $80.1M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
James Xiaodong LiuDirectorIrvine, CA
Valerie S TaupinDirectorIrvine, CA
ROBERT E GRANTExecutive OfficerNEWPORT BEACH, CA
Alex WilsonExecutive OfficerMiami, FL
Jost FischerDirectorIrvine, CA
Robert GrantDirectorSonoma, CA
Darren O'BrienDirectorIrvine, CA
Simone BlankDirectorIrvine, CA
Marc ForthExecutive OfficerIrvine, CA
Vikram MalikDirectorIrvine, CA
Richard TaketaDirectorIrvine, CA
Chris CarrExecutive OfficerIrvine, CA
Chad OhExecutive OfficerIrvine, CA
ROBERT E GRANTDirectorNEWPORT BEACH, CA
Scott AkamineExecutive OfficerNewport Beach, CA
Hans S KeirsteadDirectorIrvine, CA
Juliet Tammenoms BakkerDirectorIrvine, CA
Craig Tammenoms KussmanExecutive OfficerIrvine, CA
William E LinkDirectorIrvine, CA
William E LinkExecutive OfficerIrvine, CA
Bosun Tammenoms HauDirectorIrvine, CA
Patrick S MaxwellDirectorIrvine, CA
Richard S LindstromDirectorIrvine, CA
Robert S HaymanDirectorIrvine, CA
Robert Tammenoms RhatiganExecutive OfficerIrvine, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2022-08-11D$30.0M$30.0M
2022-08-11D$25.0M$24.5M
2021-05-13D/A$30.0M$30.0M
2020-08-31D$25.0M$25.0M
2016-08-10D$55.0M$5.5M
2015-01-22D$40.5M$27.0M

More